WELL
Welltower Inc
$236.17-2.05%
Setup
No setup
Buy Zone
$239.77-$251.76
Sector
REIT - Healthcare Facilities
Industry
REIT - Healthcare Facilities
52
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
WELL chart
Loading chart…
ADX
Developing29.3Long Term
Up ↑Intermediate Term
Up ↑Short Term
Up ↑Overall Quality52
RS Rating
72
relative strength
Fundamentals
42
Weak fund-Q
Volume Demand
45
-29% vs avg
Technical Setup
38
3/8 checks
Industry/Theme
91
REIT - Healthcare Facilities
Trade Plan
Avoid
Entry
$239.77
Entry Zone
$239.77-$251.76
Stop / Risk
$220.59
RS Rating
72
Volume confirmed
No
Targets
$287.72 / $299.71
Breakout · IBD Setup
3 ✓ 5 ✗
Entry $239.77–$251.76Stop $220.59Target $287.72 / $299.71
Market regimeUptrend
Quality52
RS Rating72
Above 50-MA-0.39%
Above 200-MA+11.98%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
52
MarketUptrend
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q42 · Weak
StatusAvoid
Stock Data
52-Week Range164 – 255
Price % Chg YTD27.24%
Price % Chg 4wk0.07%
50-Day Avg Vol3.2 Mil
P/E Ratio—
Market Cap$170B
SectorReal Estate
IndustryREIT - Healthcare Facilities
Company Fundamentals
EPS % Chg (Qtr)12.01%
Sales % Chg (Qtr)38.96%
EPS Growth 5y-22.65%
Sales Growth 5y18.69%
Annual ROE3.77%
Gross Margin20.26%
Operating Margin5.3%
Net Margin-2.75%
Debt / Equity0.42
Setup levels
Current price
$236.17
Pivot
$239.77
Distance to buy
-7.5%
52-week range
163.75-255.21
Trigger evidence
No active trigger evidence available.
Financial health checks
3/5
Return on equity above 15%
ROE 3.77%
Net margin above 10%
Net margin -2.75%
EPS growing quarter on quarter
EPS q/q 12.01%
Sales growing quarter on quarter
Sales q/q 38.96%
Debt to equity below 1.0
D/E 0.42
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE3.77%
Net margin-2.75%
Gross margin20.26%
EPS growth q/q12.01%
Sales growth q/q38.96%
Debt / equity0.42
lower is better
Business quality
42
GradeWeak
EPS rating26
P/E—
Market cap$170B
IndustryREIT - Healthcare Facilities
Technical checks
Über 50-MA
Fail
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-08-31
Trigger date
—
Days on list
7
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.